Physician profile
Aimee Murphy
NPI 1447565734
$1,920.47
in general payments reported to CMS, 2019-2025
23 companies · $462 in 2025
The $462 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $229 · 2023: $502 · 2024: $729 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,691.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $376.08 | 2022-2025 | |
| Amgen INC. | $294.60 | 2024-2025 | Repatha, Evenity, Otezla |
| Novo Nordisk INC | $121.25 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $117.95 | 2023-2024 | Mounjaro, Zepbound |
| Sanofi-Aventis U.S. LLC | $114.84 | 2024-2025 | |
| Coloplast Corp | $110.77 | 2022 | |
| Currax Pharmaceuticals LLC | $108.15 | 2022-2023 | Contrave |
| Glaxosmithkline, LLC. | $91.94 | 2022-2025 | Arexvy, Shingrix |
| Pfizer INC. | $79.76 | 2023-2025 | |
| Astellas Pharma US INC | $75.52 | 2023-2025 | Veozah |
| Exact Sciences Corporation | $74.88 | 2023-2024 | Cologuard Collection Kit |
| Abbott Laboratories | $74.50 | 2023-2024 | Freestyle Libre 3 |
| Medtronic, INC. | $52.52 | 2022-2024 | Interstim |
| Merck Sharp & Dohme LLC | $42.28 | 2023 | Belsomra, Dificid |
| Abbvie INC. | $30.01 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $26.28 | 2023 | Rexulti |
| Ucb, INC. | $23.34 | 2024 | Nayzilam |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.72 | 2024 | Xifaxan |
| Sanofi Pasteur INC. | $19.88 | 2023 | |
| Dexcom, INC. | $18.24 | 2024 | Dexcom G6 Transmitter |
| Becton, Dickinson and Company | $17.08 | 2024 | Venclose Maven Catheter |
| Seqirus USA INC | $15.53 | 2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Sumitomo Pharma America, INC. | $14.35 | 2024 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimee Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.